Patients
Healthcare Professionals
Santen Corporate (EN)
menu
Who We Are
Who We Are
Menu Top
Who We Are
Message from the CEO
Who We Are
Message from the CEO
Santen’s Corporate Philosophy Framework
Who We Are
Santen’s Corporate Philosophy Framework
History of Santen
Who We Are
History of Santen
Corporate Executives
Who We Are
Corporate Executives
Corporate Governance
Who We Are
Corporate Governance
Digital Transformation
Who We Are
Digital Transformation
Policies and Statements
Who We Are
Policies and Statements
Overview / Map
Who We Are
Overview / Map
Global Operations
Who We Are
Global Operations
What We Do
What We Do
Menu Top
What We Do
Medium-Term Management Plan
What We Do
Medium-Term Management Plan
Efforts to Enhance Patients’ Satisfaction
What We Do
Efforts to Enhance Patients’ Satisfaction
Efforts to Enhance Product Usability
Efforts to Enhance Patients’ Satisfaction
Efforts to Enhance Product Usability
Efforts to Address Untreated Patients
Efforts to Enhance Patients’ Satisfaction
Efforts to Address Untreated Patients
Research & Development
What We Do
Research & Development
The Ophthalmic Development Process
Research & Development
The Ophthalmic Development Process
Clinical Trial Information
Research & Development
Clinical Trial Information
Production and Quality Assurance
What We Do
Production and Quality Assurance
Production
Production and Quality Assurance
Production
Safety and Quality Assurance
Production and Quality Assurance
Safety and Quality Assurance
The Ophthalmic Production Process
Production and Quality Assurance
The Ophthalmic Production Process
Partnering
What We Do
Partnering
Santen's Partnership
Partnering
Santen's Partnership
Our Partners
Partnering
Our Partners
Partnering Contact
Partnering
Partnering Contact
Sustainability
Sustainability
Menu Top
Sustainability
Sustainability at Santen
Sustainability
Sustainability at Santen
Environment
Sustainability
Environment
Social
Sustainability
Social
Governance
Sustainability
Governance
Sustainability Library
Sustainability
Sustainability Library
Investor Relations
Investor Relations
Menu Top
Investor Relations
Company Information
Investor Relations
Company Information
Message from the CEO
Company Information
Message from the CEO
Santen’s Corporate Philosophy Framework
Company Information
Santen’s Corporate Philosophy Framework
Medium-Term Management Plan
Company Information
Medium-Term Management Plan
Corporate Governance
Company Information
Corporate Governance
Corporate Executives
Company Information
Corporate Executives
Forward-Looking Statement
Company Information
Forward-Looking Statement
Sustainability
Investor Relations
Sustainability
Sustainability at Santen
Sustainability
Sustainability at Santen
Environment
Sustainability
Environment
Social
Sustainability
Social
Governance
Sustainability
Governance
Library
Sustainability
Library
Sustainability Report
Sustainability
Sustainability Report
IR Library
Investor Relations
IR Library
Latest IR Documents
IR Library
Latest IR Documents
Consolidated Performance
IR Library
Consolidated Performance
Presentation Materials・Videos
IR Library
Presentation Materials・Videos
Integrated Report (Annual Report)
IR Library
Integrated Report (Annual Report)
Data Book
IR Library
Data Book
Pipeline
IR Library
Pipeline
Accounting Standards and Definition of "Core Basis"
IR Library
Accounting Standards and Definition of "Core Basis"
Stock Information
Investor Relations
Stock Information
Stock Information
Stock Information
Stock Information
Materials for the General Meeting of Shareholders
Stock Information
Materials for the General Meeting of Shareholders
Distribution of Profits to Shareholders and Dividends
Stock Information
Distribution of Profits to Shareholders and Dividends
IR Calendar
Stock Information
IR Calendar
Analyst Coverage
Stock Information
Analyst Coverage
Innovation
Investor Relations
Innovation
Efforts to Enhance Patients' Satisfaction
Innovation
Efforts to Enhance Patients' Satisfaction
Research and Development
Innovation
Research and Development
Production
Innovation
Production
Safety and Quality Assurance
Innovation
Safety and Quality Assurance
Careers
Careers
Menu Top
Careers
Our Stories
Our Stories
Menu Top
Our Stories
News
News
Menu Top
News
Home
News
2013 News
Press Release
IR News
Information
Press Release
12.09.2013
Santen Launches Sante PC (Pouch Type), an OTC Eye Drop in Limited Quantities on December 9, 2013
12.09.2013
Santen Launches Sante ALn, an OTC Eye Drop, and Redesign Packaging for Sante AL Cool II and Sante ALFree New Eye Drop
12.09.2013
Notice on the Establishment of Subsidiary in Singapore
12.06.2013
European marketing authorization application for Ikervis has been filed to the EMA for the treatment of Dry Eye Disease
11.29.2013
Santen to Support People in the Philippines Affected by Typhoon Haiyan through Donations
Press Release
IR News
12.09.2013
Notice on the Establishment of Subsidiary in Singapore
12.06.2013
European marketing authorization application for Ikervis has been filed to the EMA for the treatment of Dry Eye Disease
11.29.2013
Santen to Support People in the Philippines Affected by Typhoon Haiyan through Donations
11.25.2013
Santen Launches Alesion® 0.05% Ophthalmic Solution for Allergic Conjunctivitis Treatment in Japan
11.22.2013
Intravitreal VEGF Inhibitor "EYLEA" Obtains Additional Indication of Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
IR News
Information
10.09.2013
Santen to release Annual Report 2013
07.29.2013
Santen to launch its New Group Website
06.03.2013
Notice of the Relocation of Head Office
Information
News Archive
